Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.67M | 2.74M | 2.23M | 2.23M | 1.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.67M | 2.74M | 2.23M | 2.23M | 1.57M |
| Cost of Revenue | 1.71M | 1.76M | 1.44M | 1.43M | 1.01M |
| Gross Profit | 958.20K | 985.30K | 796.10K | 794.40K | 558.50K |
| SG&A Expenses | 1.45M | 1.49M | 1.44M | 1.44M | 1.44M |
| Depreciation & Amortization | 164.50K | 169.20K | 176.90K | 176.60K | 108.50K |
| Other Operating Expenses | 132.30K | 136.00K | 44.80K | 44.70K | -73.30K |
| Total Operating Expenses | 3.45M | 3.55M | 3.10M | 3.09M | 2.49M |
| Operating Income | -786.50K | -808.70K | -869.20K | -867.40K | -920.50K |
| Income Before Tax | -832.80K | -856.30K | -907.70K | -905.90K | -1.34M |
| Income Tax Expenses | -1.17M | -1.20M | 300.00 | 300.00 | 300.00 |
| Earnings from Continuing Operations | 336.90K | 346.40K | -908.10K | -906.20K | -1.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 336.90K | 346.40K | -908.10K | -906.20K | -1.34M |
| EBIT | -786.50K | -808.70K | -869.20K | -867.40K | -920.50K |
| EBITDA | -697.30K | -716.90K | -781.60K | -780.00K | -893.50K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 184.36M | 184.36M | 124.74M | 124.74M | 73.45M |
| Average Diluted Shares Outstanding | 184.36M | 184.36M | 124.74M | 124.74M | 73.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |